Antibiotic resistance in hospital: Do we control the situation?

Antibiotiki i Khimioterapiya

Volumn 55, Issue 1-2, 2010, Pages 50-58

  Yakovlev, S V ^a,b   Protsenko, D N ^a,b   Shakhova, T V ^a,b   Suvorova, M P ^a,b   Ramishvili, V Sh ^a,b   Ignatenko, O V ^a,b   Yaroshetsky, A I ^a,b   Romanovsky, Yu Ya ^a,b   Eremina, L V ^a,b  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b Municipal Clinical Hospital No 7   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM; CANDIDA; CROSS INFECTION; HUMAN; MULTIDRUG RESISTANCE;

BACTERIA; CANDIDA; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS;

EID: 77953283036     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Haley R. W., Culver D. H., White J. W. et al. Am J Epidemiol 1985; 121: 159-167.
2. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, data summary from January 1996 through December 1997: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1999; 27: 279-284.
3. Centers for Disease Control and Prevention. Detailed ICU surveillance component: national nosocomial infection surveillance scheme 1-80. Atlanta, GA: Centers for Disease Control and Prevention, 1997.
4. Esen S., Leblebicioglu H. Scand J Infect Dis 2004; 36: 2: 144-148.
5. Richards M. J., Edwards J. R., Culver D. H., Gaynes R. P. National Nosocomial Infections Surveillance System. Crit Care Med 1999; .7: 5: 887-892.
6. Vincent J. L., Bihari D. J., Suter P. M. et al. JAMA 1995; 274: 639-644.
7. Vincent J. L. Intensive Care Med 2000; 26: Suppll: S3-8.
8. Clark N. M., Hershberger E., Zervos M. J., Lynch J. P. OUT Opin Crit Care 2003; 9: 403-412.
9. Linares J. Clin Microbiol Infect 2001; 7: Suppl 4:8-15.
10. Cosgrove S. E., Sakoulas G., Parencevich E. N. et al. Clin Infect Dis 2003; 36: 53-59.
11. Gonzales C., Rubio M., Romero- Vivas J. et al. Clin Infect Dis 1999; 29: 1171-1177.
12. Eguia J., Chambers H. Semin Resp Crit Care Med 2003; 24: 37-48.
13. Wunderink R. G., Rello J., Cammarata S. K. et al. Chest 2003; 124: 1789-1797.
14. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002; 30: 458-475.
15. Weber S., GoId H. Semin Resp Crit Care Med 2003; 24: 49-60.
16. Nathisuwan S., Burgess D. S., Lewis J. S. Pharmacotherapy 2001; 21: 8: 920-928.
17. Knothe H., Shah P., Kremery V. et al. Infection 1983; 11: 315-317.
18. Babini G. S., Livermore D. M. J Antimicrob Chemother 2000; 45: 183-189.
19. Fluit A. C., Jones M. E., Schmitz F. J. et al. Clin Infect Dis 2000; 30: 454-460.
20. Gunseren F., Mamikoglu L., Ozturk S. et al. J Antimicrob Chemother 1999; 43: 373-378.
21. Paterson D. L. Curr Opin Infect Dis 2001; 14:697-701.
22. Rahal J. J. Clin Microb Infect 2000; 6: Suppl 2:2-6.
23. Paterson D. L. 21st ICC, Birmingham, 1999. Abstract.
24. Schiappa D. A., Hayden M. K., Matushek M. G. et al. J infect Dis 1996; 174: 529-536.
25. Andes D., Craig W. A. 41th Interscience Conference on Antimicrobial Agents and Chemotherapy, December 2001; Abstract.
26. Gutmann L., Heritier C., Nordmann P. et al. Antimicrob Agents Chemother 2003; 47: 755-758.
27. Pollack M. Pseudomonas aeruginosa. In: Principles and Practice of Infectious Diseases, 4th ed. / Ed. By Mandell G. L., Bennett J. E., Dolin R.. Churchill Livingstone, London, UK, 1995; 1980-2003.
28. Giamarellou H. J Antimicrob Chemother 2002; 49:229-233.